• Advance Auto Parts: J.P. Morgan lowers price target. Maintains overweight rating.
  • Axsome Therapeutics: Truist Securities adjusts price target to $150 from $100. Reiterates buy rating.
  • Bruker: Citi upgrades to buy from neutral. PT up 34% to $80.
  • CinCor Pharma: Piper Sandler starts at overweight with $73 price target.
  • Federal Signal: KeyBanc reiterates overweight rating. PT moves to $51 from $44.
  • Foot Locker:  Williams Trading upgrades to hold from sell. PT down 25% to $29.
  • Herc Holdings: KeyBanc maintains overweight rating. PT increase to $165 from $130.
  • Intercept Pharmaceuticals: Raymond James keeps outperform rating. Price target adjusts to $28 from $26.
  • Intra-Cellular Therapies: Goldman Sachs cuts to neutral from buy. Price target lowers to $49 from $64.
  • Millicom International Cellular: HSBC reinstated coverage with a recommendation of reduce. PT down 10% to $14.
  • Snowflake: Capital One Securities initiated coverage with a recommendation of equal-weight. PT set to $182, implies a 13% decrease from last price.
  • Ulta Beauty: J.P. Morgan maintains overweight rating. Price target up to $500 from $480.
  • VF: Cowen cut the recommendation to market perform from outperform. PT upgrades 9.8% to $50.
  • Vipshop Holdings: Credit Suisse raised the recommendation to outperform from neutral. PT up 20% to $12.
  • Williams-Sonoma: J.P. Morgan raised the target to $135 from $114. Maintains underweight rating.